Furthermore, DCN, ITGB1, NOTCH3 and SPARC genes were discovered to be strongly associated not only with tumor response to nCRT but also with disease-free survival; they were further used to form a four-gene expression-based risk score [86]. This evidence concerns the gene SPARC and neoplasm.